For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220926:nRSZ5367Aa&default-theme=true
RNS Number : 5367A Sivota PLC 26 September 2022
26 September 2022
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE,
PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN
OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA,
JAPAN, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY JURISDICTION IN
WHICH IT WOULD BE UNLAWFUL TO DO SO.
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION REGARDING SIVOTA PLC. NOTHING
IN THIS ANNOUNCEMENT OR THE PROSPECTUS CONSTITUTES AN OFFER TO SELL OR A
SOLICITATION OF AN OFFER TO BUY ANY SECURITIES IN ANY TERRITORY.
SIVOTA PLC
("Sivota," or "the Company")
Readmission of the entire issued Ordinary Share capital to the Official List
(by way of a Standard Listing under Chapter 14 of the Listing Rules) and to
trading on the London Stock Exchange's Main Market for listed securities
Further to the announcement of 22 September 2022, the board of Sivota is
pleased to announce the readmission of its entire issued share capital, being
12,585,000 ordinary shares of £0.01 each to the Official List (by way of a
Standard Listing under Chapter 14 of the Listing Rules) and to trading on the
London Stock Exchange's Main Market for listed securities.
For further information, please visit www.sivotacapital.com or contact:
Sivota PLC via Vigo Consulting
Tim Weller, Non-Executive Chairman
Ziv Ben-Barouch, Chief Executive Officer
Canaccord Genuity Limited + 44 (0) 20 7523 8000
Alex Aylen - Head of Equities
Vigo Consulting + 44 (0)20 7390 0230
Jeremy Garcia
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCUVVNRUVUKUAR